Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Altamont, Amex, Annex, article, assay, attended, Bachelor, blocker, buyer, CA, castor, cobomarsen, CRESA, CTA, currency, delist, delisted, delisting, denominated, DMC, Drawbridge, envelope, estate, Euro, figure, forfeited, identification, infused, Instruction, invitation, Jose, lessee, Mapp, margin, occurrence, overt, Pearson, pecuniary, philosophy, point, Poland, Pound, real, Realty, regain, retrospective, Riley, RiVax®development, RiVax®to, Setren, Smallberg, stand, Stanford, suspected, ThermoVax®in, Tisch, translated, translation, Trump, twenty, unblinded, underwriter, underwritten, VitriVax, vitro, Zolina
Removed:
Accelera, accredited, accreted, affiliated, Alder, ambient, background, Carlo, Cellceutix, Cervarix, Cervarix®were, cervical, committed, conversion, demonstration, derivative, determining, discount, DVM, East, eliminating, elimination, embedded, enable, Erba, Excellence, Farmaceutiche, Farmitalia, feature, Garcea, Gentium, GVHD, HPV, immunized, imputed, indexed, India, instrument, Italian, Joseph, Letter, manager, Marco, Maxim, Milan, multivalent, Nerviano, NMS, OTC, OTCQB, participate, Pfizer, Pharmacia, photo, promissory, Randolph, reclassified, recognizing, reconciliation, registering, replace, retained, seed, settlement, spa, surrender, Switzerland, Toxicologist, toxicology, unit, Upjohn, variable, veterinary, Warusz
Filing tables
Filing exhibits
- 10-K Annual report
- 10.30 First Amendment to Employment Agreement Dated As of April 1, 2019 Between the Company and Richard Straube, M.D.
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Eisneramper LLP
- 31.1 Certification of the Chief Executive Officer Pursuant to Exchange Act Rule 13(A)-14(A) (Under Section 302 of the Sarbanes-oxley Act of 2002).
- 31.2 Certification of the Chief Financial Officer Pursuant to Exchange Act Rule 13(A)-14(A) (Under Section 302 of the Sarbanes-oxley Act of 2002).
- 32.1 Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- 32.2 Certification of the Chief Financial Officer Pursuant to Section 906 of the Sarbanes-oxley Act of 2002.
- Download Excel data file
- View Excel data file
SNGX similar filings
Filing view
External links
EXHIBIT 21.1
SUBSIDIARIES OF SOLIGENIX, INC.
The following represents a list of Soligenix, Inc.’s subsidiaries:
Name | Ownership | State of Incorporation | |||||
Enteron Pharmaceuticals, Inc. | 100.00 | % | Delaware | ||||
Orasomal Technologies Inc. | 75.30 | % | Delaware | ||||
DOR BioDefense Corp. | 100.00 | % | Delaware | ||||
Soligenix BioPharma Canada Incorporated | 100.00 | % | Canada | ||||
Soligenix UK Limited | 100.00 | % | United Kingdom |